Deirdre J. Cohen, MD, assistant professor, Department of Medicine, NYU Langone Medical Center, discusses emerging agents for the treatment of patients with gastric cancer.
Deirdre J. Cohen, MD
Advertisement
Articles by Deirdre J. Cohen, MD
Dr. Deirdre Cohen, from NYU Medical Oncology Associates, Addresses the Role of the Hedgehog Pathway
Dr. Deirdre Cohen, NYU Medical Oncology Associates, Discusses Hedgehog Pathway Inhibition
Advertisement
Latest Updated Articles
Dr. Cohen Discusses Hedgehog Pathway InhibitionPublished: January 13th 2012 | Updated:
Dr. Cohen Addresses the Role of the Hedgehog PathwayPublished: January 30th 2012 | Updated:
Dr. Deirdre Cohen on Emerging Agents in Gastric CancerPublished: April 6th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5